HEADER TRANSFERASE/TRANSFERASE INHIBITOR 25-JAN-13 4IXC TITLE CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE IN COMPLEX WITH A SMALL TITLE 2 MOLECULE ACTIVATOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE ISOFORM 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GLUCOKINASE; COMPND 5 SYNONYM: HEXOKINASE TYPE IV, HK IV, HEXOKINASE-4, HK4, HEXOKINASE-D; COMPND 6 EC: 2.7.1.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GCK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALLOSTERIC REGULATION, BINDING SITES, CATALYTIC DOMAIN, DIABETES KEYWDS 2 MELLITUS, TYPE 2, ENZYME ACTIVATORS, GLUCOKINASE, HEXOKINASE, KEYWDS 3 HUMANS, MODELS, MOLECULAR, MUTATION, PROTEIN CONFORMATION, KEYWDS 4 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.J.OGG,D.HARGREAVES,S.GERHARDT REVDAT 2 29-JUL-20 4IXC 1 COMPND REMARK SEQADV HETNAM REVDAT 2 2 1 SSBOND LINK SITE REVDAT 1 24-APR-13 4IXC 0 JRNL AUTH M.J.WARING,S.N.L.BENNETT,S.BOYD,L.CAMPBELL,R.D.M.DAVIES, JRNL AUTH 2 S.GERHARDT,D.HARGREAVES,N.G MARTIN,G.R.ROBB,G.WILKINSON JRNL TITL MATCHED TRIPLICATE DESIGN SETS IN THE OPTIMISATION OF JRNL TITL 2 GLUCOKINASE ACTIVATORS MAXIMISING MEDICINAL CHEMISTRY JRNL TITL 3 INFORMATION CONTENT JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 3 NUMBER OF REFLECTIONS : 29871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1613 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1139 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 46.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE SET COUNT : 47 REMARK 3 BIN FREE R VALUE : 0.5170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3457 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 252 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.27000 REMARK 3 B22 (A**2) : -1.27000 REMARK 3 B33 (A**2) : 2.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.196 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.185 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.131 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.995 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3557 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3354 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4782 ; 1.871 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7713 ; 0.864 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 440 ; 6.495 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 167 ;38.826 ;23.892 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 646 ;15.494 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;18.748 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 527 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4011 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 799 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 459 REMARK 3 ORIGIN FOR THE GROUP (A): 63.1923 25.7267 0.2043 REMARK 3 T TENSOR REMARK 3 T11: 0.0380 T22: 0.0383 REMARK 3 T33: 0.0664 T12: -0.0114 REMARK 3 T13: 0.0239 T23: -0.0250 REMARK 3 L TENSOR REMARK 3 L11: 0.3759 L22: 0.5340 REMARK 3 L33: 0.2468 L12: -0.3867 REMARK 3 L13: -0.1779 L23: 0.0473 REMARK 3 S TENSOR REMARK 3 S11: 0.0349 S12: 0.0085 S13: 0.1267 REMARK 3 S21: -0.0320 S22: 0.0059 S23: -0.1189 REMARK 3 S31: 0.0237 S32: -0.0295 S33: -0.0408 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4IXC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077327. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL MULTILAYER REMARK 200 MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31632 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 54.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : 5.820 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.84 REMARK 200 R MERGE FOR SHELL (I) : 0.30900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% GLUCOSE, 10-18% PEG8000, 200MM REMARK 280 SODIUM ACETATE, MMT 100MM PH7.0-8.5, PH 7.4, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.91200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 21.45600 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 64.36800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 10 REMARK 465 SER A 11 REMARK 465 SER A 12 REMARK 465 GLU A 95 REMARK 465 GLU A 96 REMARK 465 GLY A 97 REMARK 465 THR A 342 REMARK 465 ALA A 460 REMARK 465 CYS A 461 REMARK 465 MET A 462 REMARK 465 LEU A 463 REMARK 465 GLY A 464 REMARK 465 GLN A 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 131 CB SER A 131 OG -0.080 REMARK 500 GLU A 196 CD GLU A 196 OE2 -0.071 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 73 CB - CG - OD1 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP A 73 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG A 250 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 151 57.43 -95.82 REMARK 500 LYS A 172 -4.45 -142.06 REMARK 500 SER A 418 -4.70 -140.29 REMARK 500 GLU A 443 33.99 -150.27 REMARK 500 LYS A 458 54.89 -67.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 501 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 238 O REMARK 620 2 VAL A 241 O 90.9 REMARK 620 3 VAL A 244 O 148.8 76.2 REMARK 620 4 GLY A 246 O 77.4 163.7 108.2 REMARK 620 5 HOH A 797 O 110.2 96.6 99.6 98.0 REMARK 620 N 1 2 3 4 DBREF 4IXC A 13 465 UNP P35557 HXK4_HUMAN 13 465 SEQADV 4IXC GLY A 10 UNP P35557 EXPRESSION TAG SEQADV 4IXC SER A 11 UNP P35557 EXPRESSION TAG SEQADV 4IXC SER A 12 UNP P35557 EXPRESSION TAG SEQADV 4IXC ALA A 27 UNP P35557 GLU 27 ENGINEERED MUTATION SEQADV 4IXC ALA A 28 UNP P35557 GLU 28 ENGINEERED MUTATION SEQADV 4IXC ALA A 51 UNP P35557 GLU 51 ENGINEERED MUTATION SEQADV 4IXC ALA A 52 UNP P35557 GLU 52 ENGINEERED MUTATION SEQRES 1 A 456 GLY SER SER ASN SER GLN VAL GLU GLN ILE LEU ALA GLU SEQRES 2 A 456 PHE GLN LEU GLN ALA ALA ASP LEU LYS LYS VAL MET ARG SEQRES 3 A 456 ARG MET GLN LYS GLU MET ASP ARG GLY LEU ARG LEU GLU SEQRES 4 A 456 THR HIS ALA ALA ALA SER VAL LYS MET LEU PRO THR TYR SEQRES 5 A 456 VAL ARG SER THR PRO GLU GLY SER GLU VAL GLY ASP PHE SEQRES 6 A 456 LEU SER LEU ASP LEU GLY GLY THR ASN PHE ARG VAL MET SEQRES 7 A 456 LEU VAL LYS VAL GLY GLU GLY GLU GLU GLY GLN TRP SER SEQRES 8 A 456 VAL LYS THR LYS HIS GLN MET TYR SER ILE PRO GLU ASP SEQRES 9 A 456 ALA MET THR GLY THR ALA GLU MET LEU PHE ASP TYR ILE SEQRES 10 A 456 SER GLU CYS ILE SER ASP PHE LEU ASP LYS HIS GLN MET SEQRES 11 A 456 LYS HIS LYS LYS LEU PRO LEU GLY PHE THR PHE SER PHE SEQRES 12 A 456 PRO VAL ARG HIS GLU ASP ILE ASP LYS GLY ILE LEU LEU SEQRES 13 A 456 ASN TRP THR LYS GLY PHE LYS ALA SER GLY ALA GLU GLY SEQRES 14 A 456 ASN ASN VAL VAL GLY LEU LEU ARG ASP ALA ILE LYS ARG SEQRES 15 A 456 ARG GLY ASP PHE GLU MET ASP VAL VAL ALA MET VAL ASN SEQRES 16 A 456 ASP THR VAL ALA THR MET ILE SER CYS TYR TYR GLU ASP SEQRES 17 A 456 HIS GLN CYS GLU VAL GLY MET ILE VAL GLY THR GLY CYS SEQRES 18 A 456 ASN ALA CYS TYR MET GLU GLU MET GLN ASN VAL GLU LEU SEQRES 19 A 456 VAL GLU GLY ASP GLU GLY ARG MET CYS VAL ASN THR GLU SEQRES 20 A 456 TRP GLY ALA PHE GLY ASP SER GLY GLU LEU ASP GLU PHE SEQRES 21 A 456 LEU LEU GLU TYR ASP ARG LEU VAL ASP GLU SER SER ALA SEQRES 22 A 456 ASN PRO GLY GLN GLN LEU TYR GLU LYS LEU ILE GLY GLY SEQRES 23 A 456 LYS TYR MET GLY GLU LEU VAL ARG LEU VAL LEU LEU ARG SEQRES 24 A 456 LEU VAL ASP GLU ASN LEU LEU PHE HIS GLY GLU ALA SER SEQRES 25 A 456 GLU GLN LEU ARG THR ARG GLY ALA PHE GLU THR ARG PHE SEQRES 26 A 456 VAL SER GLN VAL GLU SER ASP THR GLY ASP ARG LYS GLN SEQRES 27 A 456 ILE TYR ASN ILE LEU SER THR LEU GLY LEU ARG PRO SER SEQRES 28 A 456 THR THR ASP CYS ASP ILE VAL ARG ARG ALA CYS GLU SER SEQRES 29 A 456 VAL SER THR ARG ALA ALA HIS MET CYS SER ALA GLY LEU SEQRES 30 A 456 ALA GLY VAL ILE ASN ARG MET ARG GLU SER ARG SER GLU SEQRES 31 A 456 ASP VAL MET ARG ILE THR VAL GLY VAL ASP GLY SER VAL SEQRES 32 A 456 TYR LYS LEU HIS PRO SER PHE LYS GLU ARG PHE HIS ALA SEQRES 33 A 456 SER VAL ARG ARG LEU THR PRO SER CYS GLU ILE THR PHE SEQRES 34 A 456 ILE GLU SER GLU GLU GLY SER GLY ARG GLY ALA ALA LEU SEQRES 35 A 456 VAL SER ALA VAL ALA CYS LYS LYS ALA CYS MET LEU GLY SEQRES 36 A 456 GLN HET NA A 501 1 HET GLC A 502 12 HET 1JD A 503 33 HETNAM NA SODIUM ION HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM 1JD (2S)-2-{[1-(3-CHLOROPYRIDIN-2-YL)-1H-PYRAZOLO[3,4- HETNAM 2 1JD D]PYRIMIDIN-4-YL]OXY}-N-(5-METHYLPYRIDIN-2-YL)-3- HETNAM 3 1JD (PROPAN-2-YLOXY)PROPANAMIDE FORMUL 2 NA NA 1+ FORMUL 3 GLC C6 H12 O6 FORMUL 4 1JD C22 H22 CL N7 O3 FORMUL 5 HOH *252(H2 O) HELIX 1 1 ASN A 13 ALA A 21 1 9 HELIX 2 2 GLU A 22 GLN A 24 5 3 HELIX 3 3 GLN A 26 ARG A 46 1 21 HELIX 4 4 ARG A 46 ALA A 51 1 6 HELIX 5 5 PRO A 111 THR A 116 1 6 HELIX 6 6 THR A 118 HIS A 137 1 20 HELIX 7 7 ASN A 180 GLY A 193 1 14 HELIX 8 8 ASN A 204 ASP A 217 1 14 HELIX 9 9 GLN A 239 VAL A 241 5 3 HELIX 10 10 GLU A 256 PHE A 260 5 5 HELIX 11 11 LEU A 271 SER A 280 1 10 HELIX 12 12 GLN A 287 LEU A 292 1 6 HELIX 13 13 GLY A 294 ASP A 311 1 18 HELIX 14 14 LEU A 315 GLU A 319 5 5 HELIX 15 15 GLU A 322 THR A 326 5 5 HELIX 16 16 GLU A 331 ASP A 341 1 11 HELIX 17 17 ARG A 345 LEU A 355 1 11 HELIX 18 18 SER A 360 SER A 396 1 37 HELIX 19 19 GLY A 410 HIS A 416 1 7 HELIX 20 20 SER A 418 THR A 431 1 14 HELIX 21 21 GLU A 443 LYS A 458 1 16 SHEET 1 A 6 LEU A 58 ARG A 63 0 SHEET 2 A 6 ARG A 250 ASN A 254 -1 O CYS A 252 N VAL A 62 SHEET 3 A 6 CYS A 230 GLU A 237 -1 N TYR A 234 O VAL A 253 SHEET 4 A 6 CYS A 220 VAL A 226 -1 N ILE A 225 O ASN A 231 SHEET 5 A 6 MET A 402 ASP A 409 1 O GLY A 407 N MET A 224 SHEET 6 A 6 CYS A 434 GLU A 440 1 O ILE A 439 N VAL A 406 SHEET 1 B 5 SER A 100 SER A 109 0 SHEET 2 B 5 ASN A 83 GLY A 92 -1 N LYS A 90 O LYS A 102 SHEET 3 B 5 GLY A 72 LEU A 79 -1 N GLY A 72 O VAL A 91 SHEET 4 B 5 LEU A 144 PHE A 150 1 O THR A 149 N LEU A 77 SHEET 5 B 5 MET A 197 VAL A 203 1 O ASP A 198 N LEU A 146 SHEET 1 C 2 VAL A 154 ASP A 158 0 SHEET 2 C 2 LYS A 161 LEU A 164 -1 O LYS A 161 N GLU A 157 SSBOND 1 CYS A 213 CYS A 220 1555 1555 2.08 LINK O MET A 238 NA NA A 501 1555 1555 2.28 LINK O VAL A 241 NA NA A 501 1555 1555 2.37 LINK O VAL A 244 NA NA A 501 1555 1555 2.32 LINK O GLY A 246 NA NA A 501 1555 1555 2.56 LINK NA NA A 501 O HOH A 797 1555 1555 2.29 CRYST1 77.628 77.628 85.824 90.00 90.00 90.00 P 41 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012882 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012882 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011652 0.00000